Bionano Genomics Inc (BNGO)
0.2402
-0.02
(-6.14%)
USD |
NASDAQ |
Nov 15, 10:44
Bionano Genomics Cash and Short Term Investments (Quarterly): 18.94M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 18.94M |
| March 31, 2024 | 52.77M |
| December 31, 2023 | 101.89M |
| September 30, 2023 | 63.58M |
| June 30, 2023 | 77.06M |
| March 31, 2023 | 95.81M |
| December 31, 2022 | 113.19M |
| September 30, 2022 | 180.19M |
| June 30, 2022 | 187.34M |
| March 31, 2022 | 216.47M |
| December 31, 2021 | 250.61M |
| September 30, 2021 | 326.07M |
| June 30, 2021 | 332.55M |
| March 31, 2021 | 362.06M |
| Date | Value |
|---|---|
| December 31, 2020 | 38.45M |
| September 30, 2020 | 18.87M |
| June 30, 2020 | 17.19M |
| March 31, 2020 | 8.144M |
| December 31, 2019 | 17.31M |
| September 30, 2019 | 8.225M |
| June 30, 2019 | 15.29M |
| March 31, 2019 | 20.83M |
| December 31, 2018 | 16.52M |
| September 30, 2018 | 20.66M |
| June 30, 2018 | 7.624M |
| March 31, 2018 | 7.553M |
| December 31, 2017 | 1.022M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
8.144M
Minimum
Mar 2020
362.06M
Maximum
Mar 2021
130.45M
Average
95.81M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Revvity Inc | 1.230B |
| Bruker Corp | 148.10M |
| Azenta Inc | 595.84M |
| Harvard Bioscience Inc | 4.569M |
| Akoya Biosciences Inc | 45.22M |